An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care

Background: There is considerable interest in the use of cannabinoids for symptom control in palliative care, but there is little high-quality evidence to guide clinical practice. Objectives: Assess the feasibility of using global symptom burden measures to assess response to medicinal cannabis, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Good, Phillip D., Greer, Ristan M., Huggett, Georgina E., Hardy, Janet R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232640/
https://www.ncbi.nlm.nih.gov/pubmed/31800354
http://dx.doi.org/10.1089/jpm.2019.0540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232640/
https://www.ncbi.nlm.nih.gov/pubmed/31800354
http://dx.doi.org/10.1089/jpm.2019.0540

Ejemplares similares